Since the first reports of coronavirus (COVID-19) in Wuhan, China in December 2019 there have been more than 823,000 confirmed cases and over 45,000 deaths in 2 1 April 2020
As the world watches aghast, the novel coronavirus continues to spread its tentacles around the globe, with cases of COVID-19 rising to nearly 375,000 on Tuesda 25 March 2020
In early December 2019, the first cases of a new coronavirus emerged, a virus that has since come to grip the world’s media and worry regulators in every countr 24 February 2020
Every drug developer with ambitions to be part of the precision medicine revolution knows that improved detection rates are key to treating diseases earlier and 11 February 2020
When Dr Edward Squibb rented space in a Brooklyn brownstone in 1858, nobody could have predicted what his new pharma venture would evolve into. 15 January 2020
A little over five years ago, British drugmaker GlaxoSmithKline was riding high, following multiple years of strong sales and related year-on-year share price g 15 November 2019
For the last five years or so, the narrative around the Swiss pharma giant Roche has been about a company that is likely to be hit harder than any other by the 4 November 2019
For more than a decade, the main area of interest and focus in oncology has been the astonishing progress of immuno-oncology therapies, led lately by the all-co 14 October 2019
While there are several commonly-cited reasons for the present pre-eminence of the Cambridge-Boston biotech cluster, it's clear that the hub is greater than the 16 September 2019
The UK’s departure from the European Union looks likely to dent many sectors at least in the short to medium term, but the biopharmaceutical industry is one tha 23 August 2019
The global pharmaceutical industry has spent well over a trillion dollars on research and development in the last ten years, and analysts expect annual investme 5 August 2019
For many years, politicians, patients and drugmakers alike have warned about the risk posed by growing antimicrobial resistance, spurred on by liberal use of an 17 July 2019
IBM Watson Health has seen that being thought of as a pioneering company in applying artificial intelligence (AI) in healthcare can have its pros and cons, from 2 July 2019
Gross domestic product (GDP) in Japan is about $5 trillion, and the country’s pharmaceutical market is one of the largest in the world, with figures from the Mi 28 June 2019
Now that the warming Spanish sun has gone down on EULAR 2019, it’s worth considering what emerged of note from some of rheumatology’s leading players at the eve 20 June 2019
The flags have been furled, poster boards packed away, and ASCO planners are already getting ready for another year. Now, before attention turns to the next maj 17 June 2019
Despite a perceived lack of innovation that has moved the needle in the last five years, rheumatology remains a massively lucrative sector in which many of the 7 June 2019
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.